Beirne Wealth Consulting Services
ALT icon

Beirne Wealth Consulting Services’s Altimmune ALT Stock Holding History

Beirne Wealth Consulting Services’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.21M Hold
421,858
– – 0.24% 46
2026
Q2 		$1.28M Buy
421,858
+10,000
+2% +$29.9K 0.26% 40
2026
Q1 		$1.27M Buy
411,858
+35,400
+9% +$150K 0.36% 45
2025
Q4 		$1.36M Sell
376,458
-34,000
-8% -$148K 0.39% 43
2025
Q3 		$1.55M Buy
410,458
+68,000
+20% +$263K 0.37% 50
2025
Q2 		$1.33M Buy
342,458
+48,000
+16% +$260K 0.43% 39
2025
Q1 		$1.47M Hold
294,458
– – 0.52% 34
2024
Q4 		$2.12M Sell
294,458
-8,342
-3% -$63.7K 0.77% 29
2024
Q3 		$1.86M Buy
302,800
+25,000
+9% +$169K 0.65% 29
2024
Q2 		$1.85M Buy
277,800
+5,000
+2% +$36.9K 0.74% 29
2024
Q1 		$2.78M Sell
272,800
-31,000
-10% -$315K 1.18% 23
2023
Q4 		$3.42M Buy
303,800
+54,380
+22% +$227K 1.69% 13
2023
Q3 		$880K Hold
249,420
– – 0.7% 33
2023
Q2 		$880K Hold
249,420
– – 0.7% 33
2023
Q1 		$1.05M Buy
249,420
+12,400
+5% +$147K 0.74% 27
2022
Q4 		$3.9M Sell
237,020
-45,800
-16% -$514K 1.92% 11
2022
Q3 		$3.61M Sell
282,820
-1,827
-0.6% -$27K 1.37% 13
2022
Q2 		$3.33M Buy
284,647
+100,807
+55% +$622K 2.18% 10
2022
Q1 		$1.12M Buy
183,840
+47,000
+34% +$346K 0.62% 37
2021
Q4 		$1.26M Buy
136,840
+4,900
+4% +$52.1K 0.69% 26
2021
Q3 		$1.49M Sell
131,940
-1,830
-1% -$22.3K 0.85% 25
2021
Q2 		$1.32M Buy
133,770
+21,000
+19% +$287K 0.72% 28
2021
Q1 		$1.59M Buy
112,770
+36,545
+48% +$591K 0.94% 24
2020
Q4 		$860K Buy
+76,225
New +$898K 0.43% 47

Other funds holding ALT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
ALPS Advisors
ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return
BWM
Brown Wealth Management Naperville, Illinois $456M AUM 10.79% 1-Year Est. Return

Beirne Wealth Consulting Services's ALT Position: Q3 2026 in Review

Beirne Wealth Consulting Services held its Altimmune (ALT) position steady in Q3 2026 at 421,858 shares worth $1.21M. The position accounts for 0.24% of the portfolio, ranked #46.

Beirne Wealth Consulting Services first reported a position in ALT in Q4 2020 and has held it in 24 quarters since. The position peaked at $3.9M in Q4 2022. 72 funds tracked by Wall St. Rank hold ALT as of Q3 2026.

  • Beirne Wealth Consulting Services held 421,858 shares of Altimmune worth $1.21M as of Q3 2026.
  • Beirne Wealth Consulting Services left its Altimmune share count unchanged in Q3 2026.
  • Altimmune made up 0.24% of Beirne Wealth Consulting Services's portfolio in Q3 2026, its #46 holding.
  • Beirne Wealth Consulting Services first reported a position in Altimmune in Q4 2020 and has held it in 24 quarters since.
  • Beirne Wealth Consulting Services's Altimmune position peaked at $3.9M in Q4 2022.
  • 72 funds tracked by Wall St. Rank held Altimmune as of Q3 2026.

Based on Beirne Wealth Consulting Services's 13F filing for Q3 2026, filed 19 Oct 2026.